According to the statistics of the Department of Health of the Executive Yuan, the number of diabetic patients is increasing at an alarming rate year by year, making diabetes one of the top ten causes of death in China. In addition, among the top ten causes of death, diabetes is often accompanied by cerebrovascular disease, hypertension and heart disease, which makes the disease difficult to control. This is a heavy burden and loss for individuals, families, society and even the country. Therefore, the regulation of diabetes is an urgent and important issue. Diabetes is divided into two major topics: type I [insulin-dependent] diabetes and type II [insulin-independent] diabetes. 1 type diabetes mellitus may be mainly caused by personal heredity, virus infection or toxic substances destroying pancreatic cells, or by autoimmune formation of anti-cell antibodies, and cellular immunity is attacked, resulting in the pancreas not secreting insulin normally, so insulin injection is needed for treatment. At present, the cause of type 2 diabetes is not clear: it may be related to family inheritance or personal eating habits. In addition, this kind of patients are often accompanied by insulin resistance, mainly due to the excessive secretion of insulin by cells, which leads to the decrease of insulin insensitivity in peripheral tissues such as skeletal muscle, fatty muscle tissue and liver, and reduces the utilization rate of glucose in tissues, thus resulting in hyperinsulinemia. Controlling blood sugar, proper exercise and balanced diet are the three principles for treating diabetes. However, although insulin injection or oral hypoglycemic agents can effectively control blood sugar, they cannot effectively inhibit heart, blood vessels, eyes, kidneys and nervous system diseases caused by diabetic patients. Therefore, it is urgent to develop different drugs or health foods to assist clinical application, so that patients can choose more drugs, effectively control blood sugar and prevent diseases.
Milla Shengguo can change the original sour fruit into sweet fruit by changing the taste. Clinical experiments in medical animals have proved that glycoprotein can also stimulate healthy rats to secrete insulin, improve the utilization rate of sugar in surrounding tissues, and achieve the purpose of lowering blood sugar. In addition, intake of Milla fruit can inhibit hyperglycemia, improve insulin action ability and restore tissue sensitivity to insulin in type 2 diabetic rats. This study verified that Milla Guo Sheng not only has the effect of changing the original taste, but also has the ability to improve hyperglycemia, so it is very suitable as a healthy food for diabetic patients' daily diet and diabetes control.